Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Amedisys management to meet virrtually with SunTrust » 10:09
07/02/20
07/02
10:09
07/02/20
10:09
AMED

Amedisys

$205.29 /

-0.34 (-0.17%)

Virtual Meeting to be…

Virtual Meeting to be held on July 9 hosted by SunTrust.

ShowHide Related Items >><<
AMED Amedisys
$205.29 /

-0.34 (-0.17%)

AMED Amedisys
$205.29 /

-0.34 (-0.17%)

06/18/20
Fly Intel: Top five analyst upgrades
06/18/20 Benchmark
Benchmark upgrades Amedisys to Buy on expected EBITDA improvement
06/18/20 Benchmark
Amedisys upgraded to Buy from Hold at Benchmark
05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
AMED Amedisys
$205.29 /

-0.34 (-0.17%)

Over a week ago
Upgrade
Fly Intel: Top five analyst upgrades » 10:11
06/18/20
06/18
10:11
06/18/20
10:11
PNW

Pinnacle West

$77.15 /

+0.76 (+0.99%)

, AMED

Amedisys

$183.27 /

+3.47 (+1.93%)

, BMCH

BMC Stock Holdings

$25.51 /

+0.25 (+0.99%)

, PCTY

Paylocity

$140.37 /

+5.92 (+4.40%)

, CHD

Church & Dwight

$77.66 /

+2.3 (+3.05%)

, CNO

CNO Financial

$15.23 /

+0.305 (+2.04%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pinnacle West (PNW) upgraded to Overweight from Equal Weight at Barclays with analyst Eric Beaumont saying the shares are undervalued given the regulatory overhang and uncertainty associated with expected Arizona Commission Corporation turnover. 2. Amedisys (AMED) upgraded to Buy from Hold at Benchmark with analyst Bill Sutherland saying he believes the home health book of business is nearing pre-COVID levels of activity, while also contending that COVID-19 has enhanced the preference for home health over skilled nursing facilities and nursing homes. 3. BMC Stock Holdings (BMCH) upgraded to Buy from Hold at Benchmark with analyst Reuben Garner saying he thinks housing demand is improving by the day, while supply is increasingly limited, and he now believes that valuation for the group, and for BMC, could continue to move higher as the market starts to anticipate rising earnings estimates. 4. Church & Dwight (CHD) upgraded to Outperform from Neutral at Credit Suisse with analyst Kaumil Gajrawala saying the company's operating model is "designed to thrive in this environment." 5. CNO Financial (CNO) upgraded to Buy from Neutral at Goldman Sachs with analyst Alex Scott saying the shares are trading at 5.6 times on 2021 estimated free cash flow versus the sector average of 9.5 times which underappreciates the company's ability to consistently return cash to shareholders. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
PCTY Paylocity
$140.37 /

+5.92 (+4.40%)

CNO CNO Financial
$15.23 /

+0.305 (+2.04%)

CHD Church & Dwight
$77.66 /

+2.3 (+3.05%)

BMCH BMC Stock Holdings
$25.51 /

+0.25 (+0.99%)

AMED Amedisys
$183.27 /

+3.47 (+1.93%)

PNW Pinnacle West
$77.15 /

+0.76 (+0.99%)

06/18/20 Barclays
Pinnacle West upgraded to Overweight with $89 target at Barclays
06/18/20 Barclays
Pinnacle West upgraded to Overweight from Equal Weight at Barclays
06/15/20
Fly Intel: Top five analyst upgrades
06/14/20 Goldman Sachs
Pinnacle West upgraded to Buy from Neutral at Goldman Sachs
AMED Amedisys
$183.27 /

+3.47 (+1.93%)

06/18/20 Benchmark
Benchmark upgrades Amedisys to Buy on expected EBITDA improvement
06/18/20 Benchmark
Amedisys upgraded to Buy from Hold at Benchmark
05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
BMCH BMC Stock Holdings
$25.51 /

+0.25 (+0.99%)

06/18/20 Benchmark
Benchmark upgrades BMC Stock Holdings to Buy on rising housing market confidence
06/18/20 Benchmark
BMC Stock Holdings upgraded to Buy from Hold at Benchmark
06/05/20 Evercore ISI
BMC Stock Holdings downgraded to In Line from Outperform at Evercore ISI
04/13/20 DA Davidson
BMC Stock Holdings price target lowered to $24 from $34 at DA Davidson
PCTY Paylocity
$140.37 /

+5.92 (+4.40%)

06/18/20 RBC Capital
Paylocity upgraded to Outperform from Sector Perform at RBC Capital
06/18/20 RBC Capital
Paylocity upgraded to Outperform from Sector Perform at RBC Capital
05/22/20 Piper Sandler
Piper expands Software coverage, favors companies that drive automation
05/21/20 Piper Sandler
Paylocity initiated with a Neutral at Piper Sandler
CHD Church & Dwight
$77.66 /

+2.3 (+3.05%)

06/18/20 Credit Suisse
Credit Suisse upgrades Church & Dwight, says 'built to withstand' recession
06/18/20 Credit Suisse
Church & Dwight upgraded to Outperform from Neutral at Credit Suisse
05/15/20 SunTrust
Church & Dwight, Colgate Palmolive price targets raised at SunTrust
03/26/20 Barclays
Church & Dwight price target lowered to $55 from $65 at Barclays
CNO CNO Financial
$15.23 /

+0.305 (+2.04%)

06/18/20 Goldman Sachs
CNO Financial upgraded to Buy from Neutral at Goldman Sachs
05/29/20 B. Riley FBR
CNO Financial upgraded to Buy from Neutral at B. Riley FBR
05/20/20
Fly Intel: Top five analyst initiations
05/20/20 Piper Sandler
CNO Financial initiated with a Neutral at Piper Sandler
PNW Pinnacle West
$77.15 /

+0.76 (+0.99%)

PCTY Paylocity
$140.37 /

+5.92 (+4.40%)

CNO CNO Financial
$15.23 /

+0.305 (+2.04%)

CHD Church & Dwight
$77.66 /

+2.3 (+3.05%)

BMCH BMC Stock Holdings
$25.51 /

+0.25 (+0.99%)

AMED Amedisys
$183.27 /

+3.47 (+1.93%)

PCTY Paylocity
$140.37 /

+5.92 (+4.40%)

CHD Church & Dwight
$77.66 /

+2.3 (+3.05%)

PNW Pinnacle West
$77.15 /

+0.76 (+0.99%)

CHD Church & Dwight
$77.66 /

+2.3 (+3.05%)

Upgrade
Benchmark upgrades Amedisys to Buy on expected EBITDA improvement » 06:35
06/18/20
06/18
06:35
06/18/20
06:35
AMED

Amedisys

$179.80 /

+1.415 (+0.79%)

As previously reported,…

As previously reported, Benchmark analyst Bill Sutherland upgraded Amedisys to Buy from Hold with a $210 price target following the firm's House Call virtual conference earlier this week. He believes the home health book of business is nearing pre-COVID levels of activity, while also contending that COVID-19 has enhanced the preference for home health over skilled nursing facilities and nursing homes, the analyst tells investors. He has raised his estimates to reflect greater visibility into sequential EBITDA improvement in the back half of the year and into 2021, as well as the AseraCare hospice acquisition that closed on June 1.

ShowHide Related Items >><<
AMED Amedisys
$179.80 /

+1.415 (+0.79%)

AMED Amedisys
$179.80 /

+1.415 (+0.79%)

06/18/20 Benchmark
Amedisys upgraded to Buy from Hold at Benchmark
05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
AMED Amedisys
$179.80 /

+1.415 (+0.79%)

Upgrade
Amedisys upgraded to Buy from Hold at Benchmark » 06:16
06/18/20
06/18
06:16
06/18/20
06:16
AMED

Amedisys

$179.80 /

+1.415 (+0.79%)

Benchmark analyst Bill…

Benchmark analyst Bill Sutherland upgraded Amedisys to Buy from Hold with a $210 price target.

ShowHide Related Items >><<
AMED Amedisys
$179.80 /

+1.415 (+0.79%)

AMED Amedisys
$179.80 /

+1.415 (+0.79%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
AMED Amedisys
$179.80 /

+1.415 (+0.79%)

Conference/Events
Benchmark to hold a virtual conference » 08:18
06/15/20
06/15
08:18
06/15/20
08:18
AMED

Amedisys

$170.17 /

-0.15 (-0.09%)

, BEAT

BioTelemetry

$46.37 /

+1.34 (+2.98%)

, CATS

Catasys

$19.86 /

+1.42 (+7.70%)

, EXAS

Exact Sciences

$85.39 /

-3.05 (-3.45%)

, FLXN

Flexion

$11.25 /

+0.5 (+4.65%)

, HURN

Huron

$41.72 /

+0.48 (+1.16%)

, NVTA

Invitae

$16.17 /

+0.27 (+1.70%)

, LGND

Ligand

$109.29 /

-1.24 (-1.12%)

, LVGO

Livongo Health

$60.13 /

+1.17 (+1.98%)

, MTBC

MTBC

$6.70 /

+0.285 (+4.45%)

, NEO

NeoGenomics

$27.07 /

+1.08 (+4.16%)

, NEPH

Nephros

$7.98 /

+0.48 (+6.40%)

, SEEL

Seelos Therapeutics

$1.21 /

+0.135 (+12.56%)

, STAA

Staar Surgical

$42.79 /

+1.67 (+4.06%)

, TRHC

Tabula Rasa HealthCare

$53.17 /

+0.52 (+0.99%)

, VNRX

VolitionRx

$2.89 /

+ (+0.00%)

Virtual Healthcare 1:1…

Virtual Healthcare 1:1 Conference will be held on June 15-16 beginning at 9 am. Webcast Link

ShowHide Related Items >><<
VNRX VolitionRx
$2.89 /

+ (+0.00%)

TRHC Tabula Rasa HealthCare
$53.17 /

+0.52 (+0.99%)

STAA Staar Surgical
$42.79 /

+1.67 (+4.06%)

SEEL Seelos Therapeutics
$1.21 /

+0.135 (+12.56%)

NVTA Invitae
$16.17 /

+0.27 (+1.70%)

NEPH Nephros
$7.98 /

+0.48 (+6.40%)

NEO NeoGenomics
$27.07 /

+1.08 (+4.16%)

MTBC MTBC
$6.70 /

+0.285 (+4.45%)

LVGO Livongo Health
$60.13 /

+1.17 (+1.98%)

LGND Ligand
$109.29 /

-1.24 (-1.12%)

HURN Huron
$41.72 /

+0.48 (+1.16%)

FLXN Flexion
$11.25 /

+0.5 (+4.65%)

EXAS Exact Sciences
$85.39 /

-3.05 (-3.45%)

CATS Catasys
$19.86 /

+1.42 (+7.70%)

BEAT BioTelemetry
$46.37 /

+1.34 (+2.98%)

AMED Amedisys
$170.17 /

-0.15 (-0.09%)

AMED Amedisys
$170.17 /

-0.15 (-0.09%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
BEAT BioTelemetry
$46.37 /

+1.34 (+2.98%)

01/07/20 SunTrust
BioTelemetry initiated with a Buy at SunTrust
11/06/19 Lake Street
BioTelemetry price target lowered to $80 from $90 at Lake Street
08/02/19
BioTelemetry downgraded to Market Perform on moderating growth at Raymond James
08/02/19 Raymond James
BioTelemetry downgraded to Market Perform from Outperform at Raymond James
CATS Catasys
$19.86 /

+1.42 (+7.70%)

05/06/20 RBC Capital
Short report targeting Catasys 'doesn't break new ground,' says RBC Capital
04/20/20 RBC Capital
Catasys initiated with an Outperform at RBC Capital
04/20/20 Canaccord
Catasys price target raised to $35 from $26 at Canaccord
03/16/20 Canaccord
Canaccord says three focus names names have limited COVID-19 impact
EXAS Exact Sciences
$85.39 /

-3.05 (-3.45%)

05/13/20 Evercore ISI
Exact Sciences comments imply volumes last week down 40% YoY, says Evercore ISI
05/07/20 Craig-Hallum
Exact Sciences price target lowered to $92 from $99 at Craig-Hallum
05/07/20 Canaccord
Exact Sciences price target lowered to $110 from $120 at Canaccord
04/22/20 Baird
Exact Sciences price target lowered to $90 from $100 at Baird
FLXN Flexion
$11.25 /

+0.5 (+4.65%)

05/27/20 Guggenheim
Guggenheim starts coverage of four pain treatment makers with two Buys
05/26/20 Guggenheim
Flexion initiated with a Buy at Guggenheim
05/08/20 Needham
Flexion price target lowered to $20 from $30 at Needham
04/02/20 Benchmark
Flexion price target lowered to $17 from $25 at Benchmark
HURN Huron
$41.72 /

+0.48 (+1.16%)

05/01/20 Benchmark
Huron downgraded to Hold on limited visibility at Benchmark
05/01/20 Benchmark
Huron downgraded to Hold from Buy at Benchmark
01/06/20 SunTrust
Huron price target raised to $80 from $74 at SunTrust
10/31/19 Barrington
Huron price target raised to $76 from $68 at Barrington
NVTA Invitae
$16.17 /

+0.27 (+1.70%)

05/06/20 SVB Leerink
Invitae price target raised to $25 from $20 at SVB Leerink
04/02/20 Oppenheimer
Invitae price target lowered to $25 from $32 at Oppenheimer
02/20/20 Cowen
Invitae price target raised to $30 from $20 at Cowen
01/28/20 Cowen
More flexible Medicare coverage for NGS a positive for Invitae, says Cowen
LGND Ligand
$109.29 /

-1.24 (-1.12%)

06/02/20 Craig-Hallum
Ligand stock should move higher, says Craig-Hallum
04/29/20 Craig-Hallum
Ligand has 'significant upside' if remdesivir is approved, says Craig-Hallum
04/08/20 H.C. Wainwright
Ligand price target lowered to $229 from $237 at H.C. Wainwright
04/06/20 H.C. Wainwright
H.C. Wainwright says Captisol a 'key focus' for Ligand, reiterates Buy
LVGO Livongo Health
$60.13 /

+1.17 (+1.98%)

06/12/20 SVB Leerink
Livongo Health price target raised to $65 from $55 at SVB Leerink
06/05/20 Cowen
Livongo Health initiated with Outperform at Cowen
06/03/20 Canaccord
Livongo Health price target raised to $69 from $65 at Canaccord
05/22/20 JPMorgan
Livongo Health price target raised to $63 from $36 at JPMorgan
MTBC MTBC
$6.70 /

+0.285 (+4.45%)

06/02/20 Ladenburg
MTBC initiated with a Buy at Ladenburg
03/03/20
LD Micro to hold a virtual conference
03/02/20
Fly Intel: Top five analyst downgrades
03/02/20 H.C. Wainwright
MTBC downgraded to Neutral from Buy at H.C. Wainwright
NEO NeoGenomics
$27.07 /

+1.08 (+4.16%)

04/21/20 Stephens
NeoGenomics resumed with an Overweight at Stephens
03/17/20 Needham
Needham adds NeoGenomics to Conviction List, boosts target to $33
03/02/20 Craig-Hallum
NeoGenomics resumed with a Buy at Craig-Hallum
03/02/20 Raymond James
NeoGenomics price target raised to $32 from $28 at Raymond James
NEPH Nephros
$7.98 /

+0.48 (+6.40%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim
SEEL Seelos Therapeutics
$1.21 /

+0.135 (+12.56%)

11/18/19 H.C. Wainwright
Seelos Therapeutics price target lowered to $2 from $4 at H.C. Wainwright
11/14/19 Benchmark
Seelos Therapeutics initiated with a Speculative Buy at Benchmark
STAA Staar Surgical
$42.79 /

+1.67 (+4.06%)

06/15/20 Jefferies
Staar Surgical initiated with a Buy at Jefferies
03/04/20
BTIG healthcare analysts to hold an analyst/industry conference call
01/31/20 Benchmark
Too early to call China emergency impact on Staar Surgical, says Benchmark
TRHC Tabula Rasa HealthCare
$53.17 /

+0.52 (+0.99%)

04/20/20 RBC Capital
Tabula Rasa HealthCare initiated with an Outperform at RBC Capital
04/13/20 Stifel
Tabula Rasa HealthCare seen as 'one of most defensive names in HCIT' at Stifel
04/13/20 SVB Leerink
Tabula Rasa HealthCare initiated with an Outperform at SVB Leerink
03/31/20 Baird
Tabula Rasa HealthCare resilient in face of COVID-19, says Baird
VNRX VolitionRx
$2.89 /

+ (+0.00%)

05/06/20 Aegis
VolitionRx initiated with a Buy at Aegis
TRHC Tabula Rasa HealthCare
$53.17 /

+0.52 (+0.99%)

STAA Staar Surgical
$42.79 /

+1.67 (+4.06%)

NVTA Invitae
$16.17 /

+0.27 (+1.70%)

NEPH Nephros
$7.98 /

+0.48 (+6.40%)

NEO NeoGenomics
$27.07 /

+1.08 (+4.16%)

MTBC MTBC
$6.70 /

+0.285 (+4.45%)

LVGO Livongo Health
$60.13 /

+1.17 (+1.98%)

LGND Ligand
$109.29 /

-1.24 (-1.12%)

HURN Huron
$41.72 /

+0.48 (+1.16%)

FLXN Flexion
$11.25 /

+0.5 (+4.65%)

EXAS Exact Sciences
$85.39 /

-3.05 (-3.45%)

CATS Catasys
$19.86 /

+1.42 (+7.70%)

BEAT BioTelemetry
$46.37 /

+1.34 (+2.98%)

AMED Amedisys
$170.17 /

-0.15 (-0.09%)

LVGO Livongo Health
$60.13 /

+1.17 (+1.98%)

VNRX VolitionRx
$2.89 /

+ (+0.00%)

NVTA Invitae
$16.17 /

+0.27 (+1.70%)

LGND Ligand
$109.29 /

-1.24 (-1.12%)

FLXN Flexion
$11.25 /

+0.5 (+4.65%)

VNRX VolitionRx
$2.89 /

+ (+0.00%)

NVTA Invitae
$16.17 /

+0.27 (+1.70%)

LVGO Livongo Health
$60.13 /

+1.17 (+1.98%)

EXAS Exact Sciences
$85.39 /

-3.05 (-3.45%)

CATS Catasys
$19.86 /

+1.42 (+7.70%)

BEAT BioTelemetry
$46.37 /

+1.34 (+2.98%)

Over a month ago
Conference/Events
Amedisys management to meet virtually with Oppenheimer » 04:55
05/26/20
05/26
04:55
05/26/20
04:55
AMED

Amedisys

$192.56 /

+0.46 (+0.24%)

Virtual Meeting to be…

Virtual Meeting to be held on May 26 hosted by Oppenheimer.

ShowHide Related Items >><<
AMED Amedisys
$192.56 /

+0.46 (+0.24%)

AMED Amedisys
$192.56 /

+0.46 (+0.24%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
AMED Amedisys
$192.56 /

+0.46 (+0.24%)

Conference/Events
Amedisys management to meet virtually with Oppenheimer » 08:30
05/22/20
05/22
08:30
05/22/20
08:30
AMED

Amedisys

$192.10 /

+2.345 (+1.24%)

Virtual Meeting to be…

Virtual Meeting to be held on May 26 hosted by Oppenheimer.

ShowHide Related Items >><<
AMED Amedisys
$192.10 /

+2.345 (+1.24%)

AMED Amedisys
$192.10 /

+2.345 (+1.24%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
AMED Amedisys
$192.10 /

+2.345 (+1.24%)

Recommendations
SunTrust raises price targets across select Healthcare Services names » 09:17
05/21/20
05/21
09:17
05/21/20
09:17
AMED

Amedisys

$189.76 /

-0.255 (-0.13%)

, DGX

Quest Diagnostics

$113.87 /

+3.65 (+3.31%)

, HUM

Humana

$391.39 /

-4.12 (-1.04%)

, LH

LabCorp

$170.53 /

+3.57 (+2.14%)

, LHCG

LHC Group

$160.15 /

-0.63 (-0.39%)

, PNTG

The Pennant Group

$24.04 /

+0.58 (+2.47%)

, UNH

UnitedHealth

$287.98 /

-1.02 (-0.35%)

, ANTM

Anthem

$279.95 /

-1.32 (-0.47%)

SunTrust analyst David…

SunTrust analyst David MacDonald raises his price targets across a number of Healthcare Services names, noting that the re-opening and recovery phase of the pandemic should see the health care system return to more "normalized consumption in the second half of this year and in 2021. The industry's core trends remain solid, reimbursement are largely benign, the underlying demand for healthcare is not going away, and liquidity is key, the analyst tells investors in a research note, adding that he favors names with exposure to Managed Care/Home-Based Care. MacDonald raises his price targets on Amedisys (AMED) to $240 from $225, Anthem (ANTM) to $320 from $280, Quest Diagnostic (DGX) to $130 from $110, Humana (HUM) to $440 from $400, LabCorp (LH) to $220 from $200, LHC Group (LHCG) to $200 from $160, The Pennant Group (PNTG) to $28 from $23, and on UnitedHealth (UNH) to $360 from $340.

ShowHide Related Items >><<
UNH UnitedHealth
$287.98 /

-1.02 (-0.35%)

PNTG The Pennant Group
$24.04 /

+0.58 (+2.47%)

LHCG LHC Group
$160.15 /

-0.63 (-0.39%)

LH LabCorp
$170.53 /

+3.57 (+2.14%)

HUM Humana
$391.39 /

-4.12 (-1.04%)

DGX Quest Diagnostics
$113.87 /

+3.65 (+3.31%)

ANTM Anthem
$279.95 /

-1.32 (-0.47%)

AMED Amedisys
$189.76 /

-0.255 (-0.13%)

AMED Amedisys
$189.76 /

-0.255 (-0.13%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
DGX Quest Diagnostics
$113.87 /

+3.65 (+3.31%)

04/28/20
Fly Intel: Top five analyst upgrades
04/28/20 Morgan Stanley
Morgan Stanley upgrades Quest Diagnostics to Overweight on COVID testing boost
04/28/20 Morgan Stanley
Quest Diagnostics upgraded to Overweight from Equal Weight at Morgan Stanley
04/27/20
Fly Intel: Top five analyst upgrades
HUM Humana
$391.39 /

-4.12 (-1.04%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
LH LabCorp
$170.53 /

+3.57 (+2.14%)

05/15/20
Fly Intel: Top five analyst upgrades
05/15/20 Mizuho
LabCorp upgraded to Buy from Neutral at Mizuho
05/13/20 JPMorgan
Adaptive reported 'healthy' Q1 results, says JPMorgan
04/30/20 JPMorgan
LabCorp price target raised to $188 from $149 at JPMorgan
LHCG LHC Group
$160.15 /

-0.63 (-0.39%)

12/06/19 SunTrust
LHC Group price target raised to $160 from $145 at SunTrust
11/01/19 William Blair
Home health 2020 rate final rule positive for providers, says William Blair
10/21/19 Stephens
LHC Group resumed with an Overweight at Stephens
09/16/19 Deutsche Bank
LHC Group initiated with a Buy at Deutsche Bank
PNTG The Pennant Group
$24.04 /

+0.58 (+2.47%)

01/15/20 SunTrust
The Pennant Group initiated with a Hold at SunTrust
01/15/20 SunTrust
The Pennant Group initiated with a Hold at SunTrust
10/31/19 Stifel
Ensign Group upgraded to Buy from Hold at Stifel
10/22/19 RBC Capital
The Pennant Group initiated with a Sector Perform at RBC Capital
UNH UnitedHealth
$287.98 /

-1.02 (-0.35%)

04/24/20 Citi
UnitedHealth price target lowered to $339 from $346 at Citi
04/16/20 Raymond James
UnitedHealth price target lowered to $325 from $340 at Raymond James
04/16/20 Credit Suisse
UnitedHealth price target lowered to $325 from $330 at Credit Suisse
04/16/20 Cowen
UnitedHealth price target lowered to $320 from $340 at Cowen
ANTM Anthem
$279.95 /

-1.32 (-0.47%)

05/12/20 UBS
Anthem price target raised to $330 from $307 at UBS
04/21/20 Cleveland Research
Anthem 2020 outlook achievable, possibly beatable, says Cleveland Research
04/09/20 Jefferies
Anthem downgraded to Hold on Commercial Risk at Jefferies
04/09/20 Jefferies
Anthem downgraded to Hold from Buy at Jefferies
UNH UnitedHealth
$287.98 /

-1.02 (-0.35%)

PNTG The Pennant Group
$24.04 /

+0.58 (+2.47%)

LHCG LHC Group
$160.15 /

-0.63 (-0.39%)

LH LabCorp
$170.53 /

+3.57 (+2.14%)

HUM Humana
$391.39 /

-4.12 (-1.04%)

DGX Quest Diagnostics
$113.87 /

+3.65 (+3.31%)

ANTM Anthem
$279.95 /

-1.32 (-0.47%)

AMED Amedisys
$189.76 /

-0.255 (-0.13%)

UNH UnitedHealth
$287.98 /

-1.02 (-0.35%)

LHCG LHC Group
$160.15 /

-0.63 (-0.39%)

HUM Humana
$391.39 /

-4.12 (-1.04%)

ANTM Anthem
$279.95 /

-1.32 (-0.47%)

UNH UnitedHealth
$287.98 /

-1.02 (-0.35%)

LH LabCorp
$170.53 /

+3.57 (+2.14%)

HUM Humana
$391.39 /

-4.12 (-1.04%)

DGX Quest Diagnostics
$113.87 /

+3.65 (+3.31%)

ANTM Anthem
$279.95 /

-1.32 (-0.47%)

UNH UnitedHealth
$287.98 /

-1.02 (-0.35%)

LH LabCorp
$170.53 /

+3.57 (+2.14%)

HUM Humana
$391.39 /

-4.12 (-1.04%)

DGX Quest Diagnostics
$113.87 /

+3.65 (+3.31%)

ANTM Anthem
$279.95 /

-1.32 (-0.47%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/20/20
05/20
04:55
05/20/20
04:55
RDHL

RedHill Biopharma

$7.19 /

+0.28 (+4.05%)

, ANGO

AngioDynamics

$11.05 /

+0.11 (+1.01%)

, CDXS

Codexis

$11.15 /

-0.42 (-3.63%)

, AHCO

AdaptHealth

$16.68 /

+0.18 (+1.09%)

, APLT

Applied Therapeutics

$47.53 /

+2.41 (+5.34%)

, TFX

Teleflex

$346.33 /

-6.665 (-1.89%)

, UHS

Universal Health

$101.01 /

+0.55 (+0.55%)

, HRC

Hill-Rom

$98.94 /

-2.17 (-2.15%)

, NVRO

Nevro

$122.31 /

+0.47 (+0.39%)

, AMED

Amedisys

$190.01 /

-2.98 (-1.54%)

, ESTA

Establishment Labs

$16.25 /

-0.86 (-5.03%)

, HUM

Humana

$395.51 /

+4.41 (+1.13%)

, VKTX

Viking Therapeutics

$7.05 /

-0.09 (-1.26%)

, WST

West Pharmaceutical

$211.46 /

-7.14 (-3.27%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

TFX Teleflex
$346.33 /

-6.665 (-1.89%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

CDXS Codexis
$11.15 /

-0.42 (-3.63%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

AMED Amedisys
$190.01 /

-2.98 (-1.54%)

AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.15 /

-0.42 (-3.63%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$346.33 /

-6.665 (-1.89%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$101.01 /

+0.55 (+0.55%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$122.31 /

+0.47 (+0.39%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$190.01 /

-2.98 (-1.54%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$395.51 /

+4.41 (+1.13%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

TFX Teleflex
$346.33 /

-6.665 (-1.89%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

CDXS Codexis
$11.15 /

-0.42 (-3.63%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

AMED Amedisys
$190.01 /

-2.98 (-1.54%)

AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/19/20
05/19
04:55
05/19/20
04:55
RDHL

RedHill Biopharma

$6.91 /

+0.18 (+2.67%)

, ANGO

AngioDynamics

$10.94 /

+0.93 (+9.29%)

, CDXS

Codexis

$11.57 /

+0.47 (+4.23%)

, AHCO

AdaptHealth

$16.50 /

+0.21 (+1.29%)

, APLT

Applied Therapeutics

$45.12 /

+1.22 (+2.78%)

, TFX

Teleflex

$353.00 /

+18.395 (+5.50%)

, UHS

Universal Health

$100.46 /

+7.86 (+8.49%)

, HRC

Hill-Rom

$101.11 /

+1.3 (+1.30%)

, NVRO

Nevro

$121.84 /

+4.09 (+3.47%)

, AMED

Amedisys

$192.99 /

+8.12 (+4.39%)

, ESTA

Establishment Labs

$17.11 /

+0.71 (+4.33%)

, HUM

Humana

$391.10 /

-7.25 (-1.82%)

, VKTX

Viking Therapeutics

$7.14 /

+0.04 (+0.56%)

, WST

West Pharmaceutical

$218.60 /

+4.73 (+2.21%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

TFX Teleflex
$353.00 /

+18.395 (+5.50%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

CDXS Codexis
$11.57 /

+0.47 (+4.23%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

AMED Amedisys
$192.99 /

+8.12 (+4.39%)

AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.57 /

+0.47 (+4.23%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$353.00 /

+18.395 (+5.50%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$100.46 /

+7.86 (+8.49%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$121.84 /

+4.09 (+3.47%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$192.99 /

+8.12 (+4.39%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$391.10 /

-7.25 (-1.82%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

TFX Teleflex
$353.00 /

+18.395 (+5.50%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

CDXS Codexis
$11.57 /

+0.47 (+4.23%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

AMED Amedisys
$192.99 /

+8.12 (+4.39%)

AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.